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none of us have extensive experience of using deep
vein, on two occasions I have attempted anastamosis
without the gusset, I have found difficulty in persuad-
ing a rather friable 11 mm or 12 mm deep vein to
stretch over an 18 mm or 20 mm diameter aorta. On
both occasions I found the tension sufficient to cause
small tears in the vein and I feel that the basic surgical
principle of not suturing under tension by inserting
the gusset to be a more comfortable option. Perhaps
I have just been unlucky with small veins and big
aortas.
R. A. Edmondson
King's College Hospital, London
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Systemic Effects of Intermittent Claudication
Sir,
The paper by Lewis et al.1 is of importance given the
relationship between exercise in claudicants and its
associated inflammatory response.2 However, there
are several important points to raise regarding the
methodology of assessment of the systemic effects of
claudication. The use of the urine albumin to creati-
nine ratio (UACR) may not be as useful an indicator
of systemic vascular permeability as previously
thought.3 The UACR is affected by both the endo-
thelial integrity of the renal glomerulus as well as
renal haemodynamic factors. In particular, any change
in renin or catecholamine levels will alter the transglo-
merular filtration pressure and hence microalbumin
excretion. As the relationship between creatinine ex-
cretion and albumin excretion is not linear, expressing
the rate of albumin excretion as the UACR cannot
adjust fully for potential changes in renal haemo-
dynamic factors. Hence, changes to the UACR in this
study may simply be a reflection of less catecholamine
release commensurate with less pain from claudica-
tion following successful angioplasty. Mattei et al.
made a detailed analysis of the relationship between




The authors of this study1 may be surprised to learn
that the operation of Endoscopic Thoracic Sympa-
thectomy (ETS) was not invented in Vienna by Kux
but was first performed in England by Hughes in
1942.2 Is this another example of the British tradition of
allowing our inventions to be developed elsewhere?
The questions and answers in this survey show just
how far we have lagged behind the rest of the world:
 The procedure is now abbreviated to ETS.
 Double-lumen anaesthesia has been abandoned.
 Bilateral procedures are always performed.
 Vascular disorders rarely respond to ETS.
 The Kuntz nerve is not a cause of failure.
 Use of an infraclavicular port is uncommon.
 Isolated axillary hyperhidrosis is best treated by
Botox injection.
Support for all these statements comes from the 4th
International Symposium on Sympathetic Surgery
held in Finland in June 2001. (The proceedings have
been published in Annales Chirurgiae Volume 90,
No 3). Only two consultants and two trainees from
the U.K. attended this meeting. It was decided to form
an International Society for Sympathetic Surgery
(under the Presidency of Dr Christer Drott) which
will be formally launched at the next meeting in Erlan-
gen in 2003. I would encourage all U.K. surgeons
performing ETS to contact me so they may go on theEur J Vasc Endovasc Surg Vol 23, June 2002mailing-list for the society. Hopefully this would help




1 Khan AZ, Morgan, SC, Currie IC, Lewis P, Lewis DR. Current
Practice of Transthoracic Endoscopic Sympathectomy in the South
West of England: an E-mail Survey. Eur J Vasc Endovasc Surg 2001;
22: 373±375.
2 Hughes J. Endothoracic sympathectomy. Proc Roy Soc Med 1942;
35: 585±586.
No reply received
